The improvement in insulin sensitivity and the consequent low er flow of free fatty acids to the liver, together with the increase in adiponectin (a cytokine with hepatoprotective and anti-inflammatory effects), could be key factors contributing to the reduction in steatosis and liver inflammation. This evidence concerns the gene ADIPOQ and steatosis.